Radiolabeling of fab and f(ab′) 2 antibody fragments with 99mTc(I) tricarbonyl core using a new bifunctional tridentate ligand

Nuclear Medicine Communications

Volumn 32, Issue 4, 2011, Pages 324-329

  Misri, Ripen ^a   Saatchi, Katayoun ^a   Häfeli, Urs O ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

99mTc; bifunctional chelator; radiolabeled antibody fragments; tricarbonyl core

Indexed keywords

CARBOXYLIC ACID; CHELATING AGENT; CYANAMIDE; CYSTEINE; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MESOTHELIN; N (3 PHENOL) HISTIDINE CHELATOR; RADIOPHARMACEUTICAL AGENT; TRICARBONYL TC 99M; UNCLASSIFIED DRUG;

AMINATION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CONTROLLED STUDY; IMMUNOREACTIVITY; IN VITRO STUDY; ISOTOPE LABELING; MESOTHELIOMA; OVARY CANCER; PANCREAS CANCER; RADIOCHEMISTRY;

CELL LINE; CHELATING AGENTS; CYSTEINE; HISTIDINE; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FAB FRAGMENTS; ISOTOPE LABELING; LIGANDS; MOLECULAR STRUCTURE; PHENOLS; RADIOPHARMACEUTICALS; RECEPTORS, IMMUNOLOGIC; TECHNETIUM;

EID: 79952440653     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328343dee5     Document Type: Article

References (33)

1. Mahmood A, Jones AG. Technetium radiopharmaceuticals. In: Welch MJ Redvanly CS editors. Handbook ofradiopharmaceuticals: radiochemistry and applications. Chichester: John Wiley & Sons; 2003. 323-362.
2. Liu Y, Wu C. Radiolabeling of monoclonal antibodies with metal chelates. Pure Appl Chem 1991; 63:427-463.
3. Goldenberg DM, DeLand F, Kim E, Bennett S, Primus FJ, Van Nagell JR Jr, et al. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 1978; 298:1384-1386.
4. Goldenberg DM, Griffiths GL. Editorial: Radioimmunotherapy of cancer: arming the missiles. J Nucl Med 1992; 33:1110-1112.
5. Goldenberg DM. Targeted therapy of cancer with radiolabeled antibodies. J Nucl Med 2002; 43:693-713. (Pubitemid 34507123)
6. 99mTc-labelled monoclonal antibodies: a review. Nucl Med Commun 1993; 14:347-359. (Pubitemid 23149367)
7. 99mTc. Am Biotechnol Lab 1990; 8:50-53.
8. 99mTc-labeled conjugated antibodies using a cyclam-based bifunctional chelating agent. Int J RadAppl Instrum B 1987; 14:569-572. (Pubitemid 17141786)
9. Alberto R, Schibli R, Egli A. Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates. U. S. Patent No. 6,344,178 B1, 5 Feb 2002.
10. Bowen ML, Chen Z-F, Roos AM, Misri R, Häfeli U, Adam MJ, et al. Long-chain rhenium and technetium glucosamine conjugates. Dalton Trans 2009; 42:9228-9236.
11. + core (M = Re,Tc). Dalton Trans 2009; 42: 9216-9227.
12. 99mTc, Re): synthesis, in vitro, and in vivo behavior of the model complex [M(APPA)(CO)3] (APPA = [(5-amino-pentyl)-pyridin-2-yl-methyl-amino]-acetic acid). Nucl Med Biol 2003; 30:465-470. (Pubitemid 36780956)
13. Maresca KP, Marquis JC, Hillier SM, Lu G, Femia FJ, Zimmerman CN, et al. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide. Bioconjug Chem 2010; 21:1032-1042.
14. 99mTc- labeled recombinantVEGF bioconjugates: in vitro evaluation oftheir cytotoxicity on porcine aortic endothelial cells overexpressing Flt-1 receptors. Nucl Med Biol 2010; 37:105-115.
15. 99mTc, Re). Inorg Chem 2003; 42:2818-2820.
16. Waibel R, Alberto R, Willuda J, Finnern R, Schibli R, Stichelberger A, et al. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol 1999; 17:897-901. (Pubitemid 29416665)
17. 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression. Mol Imaging Biol 2008; 10:167-175.
18. Willuda J, Kubetzko S, Waibel R, Schubiger PA, Zangemeister-Wittke U, Pluckthun A. Tumor targeting of mono-, di-, and tetravalent anti-p185(HER-2) miniantibodies multimerized by self-associating peptides. J Biol Chem 2001; 276:14385-14392.
19. Orlova A, Nilsson FY, Wikman M, Widstrom C, Stahl S, Carlsson J, et al. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. J Nucl Med 2006; 47:512-519. (Pubitemid 46768494)
20. Chang K, Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci USA 1996; 93:136-140. (Pubitemid 26041483)
21. 111Indium-labeled monoclonal antibody K1: biodistribution study in nude mice bearing a human carcinoma xenograft expressing mesothelin. Int J Cancer 1999; 80:559-563. (Pubitemid 29047521)
22. Chowdhury PS, Vasmatzis G, Beers R, Lee B, Pastan I. Improved stability and yield of a Fv-toxin fusion protein by computer design and protein engineering of the Fv. J Mol Biol1998; 281:917-928.
23. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Jr. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 1984; 72:77-89. (Pubitemid 14091996)
24. 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts. Eur J Nucl Med Mol Imaging 2009; 36:81-93.
25. 99mTc) tricarbonyl complexes, with a tridentate NSO bifunctional agent: synthesis, structural characterization, and radiochemistry. Polyhedron 2010; 29:876-880.
26. Elwell K, Howard CG. Chemically modifying antibodies. In: Howard GC, Bethell DR, editors. Basic methods in antibody production and characterization. Florida: CRC Press; 2001. pp. 199-215.
27. - in aqueous solution and its reaction with a bifunctional ligand. JAm Chem Soc 1998; 120:7987-7988. (Pubitemid 28392089)
28. Schibli R, Schubiger PA. Current use and future potential of organometallic radiopharmaceuticals. Eur J Nucl Med Mol Imaging 2002; 29:1529-1542. (Pubitemid 35232058)
29. + precursor synthesized by conventional method and by using carbonyl kit. J Labelled Compd Rad 2004; 47:657-668. (Pubitemid 39390040)
30. 99mTc(I) tricarbonyl ion. Appl Radiat Isot 2008; 66:340-345.
31. +: a new radiopharmaceutical for imaging cell death. Bioconjug Chem 2009; 20:2071-2081.
32. Scheck RA, Francis MB. Regioselective labeling of antibodies through N-terminal transamination. ACS Chem Biol 2007; 2:247-251. (Pubitemid 47629212)
33. 99mTc. Int J Rad Appl Instrum B 1991; 18:667-676.